Form 4 for SABS SAB Biotherapeutics, Inc.
Accepted 2023-11-30 00:00:00 ET · period of report 2023-11-29 · accession 0000950170-23-066901 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-30 | 2023-11-29 | SABS | Reich Samuel J | Executive COB, Dir | P - Purchase | $0.89 | +11.0K | 219.0K | +5% | +$9,790 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-29 | P | A | 11,000 | $0.89 | 219,001 | D | — | — | (F2) Includes 1,000 shares of Common Stock held jointly by the reporting person and the reporting person's spouse. |